Skip to content

A study to compare effectiveness of LM scale potency versus centesimal scale potency of homoeopathic medicine in modifying susceptibility of children with ADHD

Comparing the effectiveness of LM scale potency versus centesimal scale potency of individualized homoeopathic medication in modifying the susceptibility of children suffering with ADHD by randomized experimental design - LM scale

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/07/034918
Enrollment
60
Registered
2021-07-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

Intervention1: Centesimal scale Potency of individualized Homoeopathic medicine: Homoeopathic similimum will be given in centesimal scale of potency i.e. 30, 200, 1000 etc.. according to the indicated

Sponsors

Nirav Rajnikant Rughani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ADHD with other physical co-morbidity. If child is taking other medical treatment then it must be pass minimum 3 months and the effect must be calculated before homoeopathic treatment started. If child is on any other therapy like Behaviour therapy, physiotherapy, occupational therapy then we will continue it but, it must be pass 6 months and assessment of changes with that therapy will be evaluated before of the intervention of homoeopathic treatment then only that child will included in the study.

Exclusion criteria

Exclusion criteria: Epilepsy and other neuro-biological illness which can affect the children hyperactive behaviour will be excluded for the study. Children, who have recent history of onset of other mode of therapy that have direct effect on modification of hyperactive behaviour of child will not be taken in for study. If children are suffering with other co-morbidity with ADHD like Autism spectrum disorder, history of drug abuse, seizure, conduct disorder, oppositional defiant disorder, mood disorder (childhood depression), tics disorder and anxiety disorder will not be taken into study.

Design outcomes

Primary

MeasureTime frame
Comparing the effectiveness of potency (centesimal scale versus LM scale) in modifying the susceptibility of children suffering with ADHD. To understand the modification of various facets of ADHD (Hyperactivity, Attention span, impulsivity) in children. To understand the state of susceptibility (Low, Moderate & high) of child and evaluate the overall improvement in it.Timepoint: 2 year 6 months

Secondary

MeasureTime frame
To analyze the differences in improvement of both the group in general and characterize the susceptibility. To understand the modification of Adaptation, Academic performance, social and occupational functioning of ADHD children. To evaluate the therapeutic response at a global level (growth and development, recurring physical complaints etc.) and understand the improvement in susceptibility.Timepoint: 2 years and 6 months

Countries

India

Contacts

Public ContactDr Chirag Shah

Smt. Malini Kishore Sanghvi Homoeopathic Medical College

chirashana@gmail.com9376939627

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026